Testing for anti-HMGCR antibodies might prove useful in the diagnosis of IIM and in the differentiation between self-limited and persistent statin associated myopathy which requires long-term immunosuppressive treatment. The gene discussed is HMGCR; the disease is acquired idiopathic inflammatory myopathy.